Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.77 |
| ▸ | CES2 | O00748 | 5/20 | 0.71 |
| ▸ | CES1 | P23141 | 5/20 | 0.71 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.54 |
| ▸ | PPARG | P37231 | 6/20 | 0.54 |
| ▸ | PPARD | Q03181 | 6/20 | 0.54 |
| ▸ | PPARA | Q07869 | 6/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16915217 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL5083248 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL28767487 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL8458168 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL29287856 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL3950801 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL6344027 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL5126810 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL609881 | 1.00 | FAAH (0.77) | FAAHCES2CES1GPR84PPARG | |
| SCHEMBL1367098 | 0.97 | FAAH (0.73) | FAAHCES2CES1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001035939-A2 | OLEAMIDE IN EPILEPSY | UNIVERSITY OF SUNDERLAND (GB) | 2001-05-25 | — | — | WO | claimed |
| US-11345655-B2 | Pseudoceramide compound and skin external composition comprising the same | NEOPHARM CO., LTD. (KR) | 2022-05-31 | — | — | US | disclosed |
| US-20180214472-A1 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | VYOME BIOSCIENCES, PVT. LTD. (IN) | 2018-08-02 | — | — | US | disclosed |
| US-9907812-B2 | Conjugate-based antifungal and antibacterial prodrugs | VYOME BIOSCIENCES PVT. LTD. (IN) | 2018-03-06 | — | — | US | disclosed |
| US-20140364595-A1 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | VYOME BIOSCIENCES (IN) | 2014-12-11 | — | — | US | disclosed |
| EP-2723452-A2 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | Vyome Biosciences Pvt Ltd (IN) | 2014-04-30 | — | — | EP | disclosed |
| WO-2012177986-A2 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | VYOME BIOSCIENCES (IN) | 2012-12-27 | — | — | WO | disclosed |
| EP-0910561-B1 | INHIBITORS OF OLEAMIDE HYDROLASE | SCRIPPS RESEARCH INST (US) | 2004-04-07 | — | — | EP | disclosed |
| WO-2001035939-A2 | OLEAMIDE IN EPILEPSY | UNIVERSITY OF SUNDERLAND (GB) | 2001-05-25 | — | — | WO | disclosed |
| US-6096784-A | Inhibitors of oleamide hydrolase | THE SCRIPPS RESEARCH INSTITUTE (US) | 2000-08-01 | — | — | US | disclosed |
| EP-0910561-A4 | INHIBITORS OF OLEAMIDE HYDROLASE | SCRIPPS RESEARCH INST (US) | 2000-06-07 | — | — | EP | disclosed |
| EP-0910561-A1 | INHIBITORS OF OLEAMIDE HYDROLASE | The Scripps Research Institute (US) | 1999-04-28 | — | — | EP | disclosed |
| US-5856537-A | Inhibitors of oleamide hydrolase | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-01-05 | — | — | US | disclosed |
| WO-1997049667-A1 | INHIBITORS OF OLEAMIDE HYDROLASE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1997-12-31 | — | — | WO | disclosed |
| US-4234464-A | Detergent bar composition and binder therefor | GAF CORPORATION (US) | 1980-11-18 | — | — | US | disclosed |
| WO-1980002154-A1 | DETERGENT BAR COMPOSITION AND BINDER THEREFOR | GAF CORP (US) | 1980-10-16 | — | — | WO | disclosed |
| US-4161491-A | Process for the production of alpha-ketocarboxylic acid amides and cycloaliphatic products | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1979-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180214472-A1 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | XPO1, UGT1A1, UGT1A10 | FAAH 2820/4885CES2 1161/4885CES1 680/4885 |
| US-11345655-B2 | Pseudoceramide compound and skin external composition comprising the same | ASAH2, CERS2, CUTA | FAAH 81/4885CES2 930/4885CES1 529/4885 |
| US-20140364595-A1 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | XPO1, MTX1, FUT5 | FAAH 2175/4885CES2 1327/4885CES1 689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.